Alerte De Sécurité sur Trade name: Kit Reag Immunodiag Vitros p PTH Intacto (iPTH); Calibrad Immunodiag VITROS p PTH Intact (iPTH) Technical name: intact parathyroid hormone (iPTH); Intact Parathyroid Hormone (iPTH) ANVISA Registration Number: 80145901321 Hazard Class: II Model Affected: Reag Immunodiag Vitros p PTH Intact (iPTH); Calibrad Immunodiag Vitros p Intact PTH (iPTH) Serial numbers affected: 0700, 0710, 0748, 0758 // Immunoassay Calibrator Vitros for Intact PTH (iPTH); product code 6802893; lots: 0728, 0738, 0768.

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par Johnson & Johnson do Brasil Ind. e Com. de Prod. para Saúde Ltda; Ortho-Clinical Diagnostics.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    2111
  • Date
    2016-10-31
  • Pays de l'événement
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    • Until further notice, be aware of positive deviation results when using VITROS Reagent Kits for iPTH. • Talk to the Laboratory Medical Director about any questions regarding previously reported results to determine the appropriate course of action. • Place this notification on your VITROS System or along with your user documentation. • In compliance with regulatory requirements, complete the Receipt Confirmation Form.
  • Cause
    Ortho clinical diagnostics (ortho) has confirmed that the results obtained from the vitros reagent kit for ipth show positive (ie, falsely elevated) deviations compared to a commercially available alternative method. ortho observed a 40% positive shift for samples with ipth concentrations <100pg / ml, when tested with vitros reagent kits for ipth, compared to the roche elecsys pth test. the data demonstrated that this deviation was consistent across all batches still valid. due to the limited availability of samples with ipth concentrations> 100 pg / ml, the investigation may take several weeks to complete. in the best interest of clients and patients, ortho reports the preliminary results and will provide additional notifications when the final results are available.
  • Action
    Field action Code 16000147 triggered under the responsibility of Johnson & Johnson do Brasil Ind. And Com. De Prod. for Health Ltda. Company will make correction in the field.